AMAG Pharmaceuticals - 33 Year Stock Price History | AMAG

Historical daily share price chart and data for AMAG Pharmaceuticals since 1986 adjusted for splits. The latest closing stock price for AMAG Pharmaceuticals as of October 15, 2019 is 11.40.
  • The all-time high AMAG Pharmaceuticals stock closing price was 76.46 on July 16, 2015.
  • The AMAG Pharmaceuticals 52-week high stock price is 23.64, which is 107.4% above the current share price.
  • The AMAG Pharmaceuticals 52-week low stock price is 6.81, which is 40.3% below the current share price.
  • The average AMAG Pharmaceuticals stock price for the last 52 weeks is 13.25.
AMAG Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 11.9916 15.7400 17.0500 8.2600 11.4000 -24.95%
2018 20.2486 14.6000 25.6500 12.3000 15.1900 14.64%
2017 19.3496 33.9500 35.8500 12.8000 13.2500 -61.93%
2016 25.3837 28.5800 36.0500 18.2700 34.8000 15.27%
2015 51.2351 42.6000 76.4600 26.2000 30.1900 -29.16%
2014 24.3539 23.9100 44.1700 17.2600 42.6200 75.54%
2013 21.7485 15.8900 27.9100 15.1100 24.2800 65.06%
2012 15.7034 18.7400 18.7400 12.5300 14.7100 -22.21%
2011 16.4948 18.0900 19.5800 13.1700 18.9100 4.48%
2010 29.8969 38.3900 51.3200 13.8500 18.1000 -52.41%
2009 41.7582 35.8700 55.9100 24.2400 38.0300 6.08%
2008 40.1271 60.1100 65.7200 18.3700 35.8500 -40.38%
2007 60.6779 59.3800 71.3400 52.1700 60.1300 0.69%
2006 33.2608 11.2300 63.9900 11.1601 59.7200 438.99%
2005 11.2554 16.0000 23.7400 6.6500 11.0800 -29.52%
2004 12.5900 13.2400 15.9100 8.1500 15.7200 20.92%
2003 7.8006 4.2500 14.8500 4.1200 13.0000 209.52%
2002 4.0414 3.7000 5.1400 3.4100 4.2000 15.07%
2001 3.5817 2.5000 4.9900 2.3130 3.6500 39.05%
2000 6.0036 4.1200 10.6300 2.3750 2.6250 -36.36%
1999 4.2531 7.1880 7.5000 3.1250 4.1250 -43.59%
1998 9.9836 8.8750 13.3800 5.3750 7.3130 -16.42%
1997 12.2304 15.7500 18.7500 8.5000 8.7500 -43.55%
1996 19.7536 25.7500 28.2500 14.8800 15.5000 -41.79%
1995 21.9803 14.5000 28.7500 14.3800 26.6300 88.46%
1994 14.0004 12.7500 17.0000 11.6300 14.1300 14.14%
1993 12.1687 13.1300 14.3800 10.0000 12.3800 -3.88%
1992 15.9337 23.7500 30.3800 11.0000 12.8800 -46.33%
1991 15.1091 9.5000 24.5000 9.0000 24.0000 157.14%
1990 8.2961 11.5000 11.6667 6.1667 9.3333 -15.15%
1989 7.8766 5.0000 11.0000 5.0000 11.0000 106.25%
1988 4.8543 3.3333 7.1667 2.8333 5.3333 60.00%
1987 5.4329 4.1667 8.0000 2.8333 3.3333 -20.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.375B $0.474B
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease patients.Combidex?, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $120.420B 13.72
Gilead Sciences (GILD) United States $81.040B 9.95
CSL (CSLLY) Australia $75.707B 0.00
Celgene (CELG) United States $71.278B 11.03
Illumina (ILMN) United States $44.479B 52.26
Vertex Pharmaceuticals (VRTX) United States $44.315B 47.89
Biogen (BIIB) United States $41.170B 7.31
Regeneron Pharmaceuticals (REGN) United States $33.034B 14.99
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.255B 11.73
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Incyte (INCY) United States $16.371B 48.18
Seattle Genetics (SGEN) United States $13.358B 0.00
Genmab (GNMSF) Denmark $12.091B 67.82
BioMarin Pharmaceutical (BMRN) United States $12.089B 0.00
Exact Sciences (EXAS) United States $11.977B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.782B 0.00
Galapagos (GLPG) Belgium $8.522B 0.00
Bio-Techne Corp (TECH) United States $7.614B 52.60
Sarepta Therapeutics (SRPT) United States $6.206B 0.00
QIAGEN (QGEN) Netherlands $6.107B 20.06
ACADIA Pharmaceuticals (ACAD) United States $5.855B 0.00
Guardant Health (GH) United States $5.723B 0.00
BeiGene (BGNE) Cayman Islands $5.672B 0.00
Amarin (AMRN) Ireland $5.437B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.045B 12.82
Exelixis (EXEL) United States $5.004B 13.01
Bluebird Bio (BLUE) United States $4.871B 0.00
Moderna (MRNA) United States $4.641B 0.00
China Biologic Products (CBPO) China $4.534B 28.30
ARGENX SE-ADR (ARGX) Netherlands $4.267B 0.00
Medicines (MDCO) United States $4.127B 0.00
Ascendis Pharma (ASND) Denmark $4.007B 0.00
Repligen (RGEN) United States $3.992B 77.46
Spark Therapeutics (ONCE) United States $3.841B 0.00
Blueprint Medicines (BPMC) United States $3.618B 0.00
MorphoSys AG (MOR) Germany $3.371B 0.00
Mirati Therapeutics (MRTX) United States $3.023B 0.00
Reata Pharmaceuticals (RETA) United States $2.884B 0.00
Alkermes (ALKS) Ireland $2.831B 0.00
Immunomedics (IMMU) United States $2.720B 0.00
Emergent Biosolutions (EBS) United States $2.713B 40.76
Genomic Health (GHDX) United States $2.563B 48.07
Genmab (GMAB) Denmark $2.508B 0.00
MyoKardia (MYOK) United States $2.470B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.467B 0.00
Arena Pharmaceuticals (ARNA) United States $2.350B 5.05
Halozyme Therapeutics (HALO) United States $2.348B 0.00
RA PHARMCTL INC (RARX) United States $2.188B 0.00
Myriad Genetics (MYGN) United States $2.180B 22.88
Acceleron Pharma (XLRN) United States $2.080B 0.00
NeoGenomics (NEO) United States $2.049B 109.61
CRISPR Therapeutics AG (CRSP) Switzerland $2.020B 0.00
Cambrex (CBM) United States $2.008B 25.39
Ligand Pharmaceuticals (LGND) United States $2.006B 25.37
Amicus Therapeutics (FOLD) United States $2.000B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.947B 0.00
Zai Lab (ZLAB) China $1.888B 0.00
Akcea Therapeutics (AKCA) United States $1.837B 0.00
UniQure (QURE) Netherlands $1.624B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.582B 0.00
Insmed (INSM) United States $1.552B 0.00
Denali Therapeutics (DNLI) United States $1.474B 0.00
REGENXBIO (RGNX) United States $1.454B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.340B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Coherus BioSciences (CHRS) United States $1.294B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.113B 0.00
Innoviva (INVA) United States $1.079B 3.12
Zymeworks (ZYME) Canada $1.077B 0.00
Alector (ALEC) United States $1.034B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.015B 0.00
Editas Medicine (EDIT) United States $1.000B 0.00
Sangamo Therapeutics (SGMO) United States $0.949B 0.00
AnaptysBio (ANAB) United States $0.948B 0.00
Fate Therapeutics (FATE) United States $0.932B 0.00
Epizyme (EPZM) United States $0.913B 0.00
ANI Pharmaceuticals (ANIP) United States $0.866B 14.46
Athenex (ATNX) United States $0.845B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.787B 27.86
Codexis (CDXS) United States $0.783B 0.00
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Cara Therapeutics (CARA) United States $0.754B 0.00
Twist Bioscience (TWST) United States $0.738B 0.00
Zealand Pharma (ZEAL) Denmark $0.733B 8.23
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Principia Biopharma (PRNB) United States $0.707B 365.63
ZIOPHARM Oncology Inc (ZIOP) United States $0.689B 0.00
WAVE Life Sciences (WVE) Singapore $0.688B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.677B 24.44
Cytokineticsorporated (CYTK) United States $0.656B 0.00
Vericel (VCEL) United States $0.638B 0.00
Mesoblast (MESO) Australia $0.617B 0.00
Arvinas (ARVN) United States $0.593B 0.00
Heska (HSKA) United States $0.569B 73.71
MiMedx (MDXG) United States $0.556B 0.00
Intellia Therapeutics (NTLA) United States $0.539B 0.00
Revance Therapeutics (RVNC) United States $0.537B 0.00
GENFIT S.A (GNFT) France $0.530B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.507B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.499B 0.00
PHARMA MAR SA (PHMMF) Spain $0.482B 0.00
Retrophin (RTRX) United States $0.480B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.455B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.445B 0.00
Intra-Cellular Therapies (ITCI) United States $0.428B 0.00
BioDelivery Sciences (BDSI) United States $0.425B 0.00
Cellectis S.A (CLLS) France $0.418B 0.00
DBV Technologies S.A (DBVT) France $0.407B 0.00
Stemline Therapeutics (STML) United States $0.385B 0.00
Arcus Biosciences (RCUS) United States $0.376B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
Syros Pharmaceuticals (SYRS) United States $0.373B 0.00
Precision BioSciences (DTIL) United States $0.366B 0.00
Agenus (AGEN) United States $0.361B 0.00
Bellus Health (BLU) Canada $0.361B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 0.00
Adverum Biotechnologies (ADVM) United States $0.341B 0.00
Kadmon Holdings (KDMN) United States $0.337B 0.00
AC Immune SA (ACIU) Switzerland $0.329B 24.35
CytomX Therapeutics (CTMX) United States $0.323B 0.00
Prothena (PRTA) Ireland $0.310B 0.00
Gritstone Oncology (GRTS) United States $0.308B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
Geron (GERN) United States $0.288B 0.00
Cel-Sci (CVM) United States $0.287B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Theratechnologies (THTX) Canada $0.285B 0.00
Protagonist Therapeutics (PTGX) United States $0.284B 0.00
Pfenex (PFNX) United States $0.281B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Scholar Rock Holding (SRRK) United States $0.279B 0.00
Puma Biotechnology (PBYI) United States $0.277B 0.00
PDL BioPharma (PDLI) United States $0.267B 6.88
Biofrontera AG (BFRA) Germany $0.265B 395.33
Dynavax Technologies (DVAX) United States $0.256B 0.00
Kindred Biosciences (KIN) United States $0.255B 0.00
MannKind (MNKD) United States $0.243B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.225B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.224B 0.00
Sutro Biopharma (STRO) United States $0.219B 0.00
Inovio Pharmaceuticals (INO) United States $0.216B 0.00
Seres Therapeutics (MCRB) United States $0.215B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.215B 0.00
Albireo Pharma (ALBO) United States $0.215B 0.00
Compugen (CGEN) Israel $0.214B 0.00
OSMOTICA PHARM (OSMT) United States $0.213B 0.00
Sorrento Therapeutics (SRNE) United States $0.210B 0.00
Athersys (ATHX) United States $0.209B 0.00
Spero Therapeutics (SPRO) United States $0.206B 0.00
Kamada (KMDA) Israel $0.205B 7.85
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Exicure (XCUR) United States $0.192B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
Palatin Technologies (PTN) United States $0.188B 5.51
Clovis Oncology (CLVS) United States $0.179B 0.00
Dyadic (DYAI) United States $0.176B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Enzo Biochem (ENZ) United States $0.174B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.171B 0.00
Affimed (AFMD) Germany $0.171B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.168B 0.00
Cue Biopharma (CUE) United States $0.167B 0.00
Senesco Technologies (ELOX) United States $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
XOMA (XOMA) United States $0.156B 0.00
Alcobra (ARCT) United States $0.153B 0.00
Five Prime Therapeutics (FPRX) United States $0.152B 0.00
Arsanis (XFOR) United States $0.146B 0.00
BioTime (LCTX) United States $0.141B 9.40
Cerecor (CERC) United States $0.138B 0.00
Northwest Biotherapeutics (NWBO) United States $0.137B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
CorMedix Inc (CRMD) United States $0.124B 0.00
NantKwest (NK) United States $0.123B 0.00
PHASEBIO PHARMA (PHAS) United States $0.119B 0.00
Acorda Therapeutics (ACOR) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Menlo Therapeutics (MNLO) United States $0.114B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.111B 0.00
Abeona Therapeutics (ABEO) United States $0.110B 0.00
Novavax (NVAX) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.109B 4.47
Paratek Pharmaceuticals (PRTK) United States $0.105B 0.00
Aptinyx (APTX) United States $0.104B 0.00
Emmaus Life Sciences (EMMA) United States $0.100B 0.00
OvaScience (MLND) United States $0.097B 0.00
Celyad SA (CYAD) Belgium $0.093B 0.00
VBI Vaccines (VBIV) United States $0.093B 0.00
Trevena (TRVN) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Fortress Biotech (FBIO) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aduro Biotech (ADRO) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.081B 0.00
Verastem (VSTM) United States $0.081B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.075B 0.00
Mersana Therapeutics (MRSN) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Selecta Biosciences (SELB) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.059B 21.59
Catabasis Pharmaceuticals (CATB) United States $0.058B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Stellar Biotechnologies (EDSA) Canada $0.044B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Unum Therapeutics (UMRX) United States $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Ophthotech (ISEE) United States $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Proteostasis Therapeutics (PTI) United States $0.040B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Alimera Sciences (ALIM) United States $0.028B 0.00
Protalix BioTherapeutics (PLX) Israel $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
BioCardia (BCDA) United States $0.024B 0.00
DiaMedica Therapeutics (DMAC) United States $0.022B 0.00
Caladrius Biosciences (CLBS) United States $0.022B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
IBio (IBIO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.002B 0.00